[Current course of infectious endocarditis].

Etiological factors, clinical manifestations, laboratory evidence and outcomes of infectious endocarditis (IE) were studied in 59 patients treated in 1981-1996. Cases of the secondary form predominated. Previously described stages (infectious-toxic, immuno-inflammatory, dystrophic) were not observed.

[Essential phospholipids in combined therapy of chronic circulatory insufficiency].

Essential phospholipids (essentiale-forte) was used in combined therapy of 36 patients with pronounced circulatory insufficiency and hepatic dysfunction. A 4-6-week course of this treatment 6 weeks after its termination resulted in good subjective response, positive changes in hemodynamics, intrahepatic cholestasis, synthetic function of the liver and lipid metabolism. The drug was well tolerated.